Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guofan Xu

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Neuroimage|December 15, 2010
Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI populationChris Hinrichs, Vikas Singh, Guofan Xu, et al.
Korean Journal of Radiology|November 1, 2021
COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CTDeanna L Lane, Sattva S Neelapu, Guofan Xu, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 16, 2023
Comparison of PSMA-based <sup>18</sup>F-DCFPyL PET/CT and Tc-99m MDP bone scan in detection of bone metastasis in prostate cancerZenus J Wilson, Guofan Xu, Sanjit O Tewari, et al.
Neuroimage|April 10, 2012
A generalized form of context-dependent psychophysiological interactions (gPPI): a comparison to standard approachesDonald G McLaren, Michele L Ries, Guofan Xu, et al.
Carbohydrate Polymers|May 12, 2023
Tackling the challenge of drying and redispersion of cellulose nanofibrils via membrane-facilitated liquid phase exchangeAmaka J Onyianta, Guofan Xu, Anita Etale, et al.
Clinical Nuclear Medicine|October 6, 2023
Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate Cancer Patients After Definitive Treatment With PSA Level ≤0.2 ng/mLYang Lu, Zenus J Wilson, Guofan Xu, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 13, 2023
Comparison of PSMA-based <sup>18</sup>F-DCFPyL PET/CT and pelvic multiparametric MRI for lesion detection in the pelvis in patients with prostate cancerTrinh T Nguyen, Priya R Bhosale, Guofan Xu, et al.
Magnetic Resonance Imaging|January 1, 2008
The phase shift index for marking functional asynchrony in Alzheimer's disease patients using fMRIYin Xu, Guofan Xu, Gaohong Wu, et al.
Neuroimage|June 2, 2009
Spatially augmented LPboosting for AD classification with evaluations on the ADNI datasetChris Hinrichs, Vikas Singh, Lopamudra Mukherjee, et al.
Current Oncology Reports|January 21, 2022
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic ApproachCamilo Jimenez, Guofan Xu, Jeena Varghese, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Neuroimage|December 15, 2010
Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI populationChris Hinrichs, Vikas Singh, Guofan Xu, et al.
Korean Journal of Radiology|November 1, 2021
COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CTDeanna L Lane, Sattva S Neelapu, Guofan Xu, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 16, 2023
Comparison of PSMA-based <sup>18</sup>F-DCFPyL PET/CT and Tc-99m MDP bone scan in detection of bone metastasis in prostate cancerZenus J Wilson, Guofan Xu, Sanjit O Tewari, et al.
Neuroimage|April 10, 2012
A generalized form of context-dependent psychophysiological interactions (gPPI): a comparison to standard approachesDonald G McLaren, Michele L Ries, Guofan Xu, et al.
Carbohydrate Polymers|May 12, 2023
Tackling the challenge of drying and redispersion of cellulose nanofibrils via membrane-facilitated liquid phase exchangeAmaka J Onyianta, Guofan Xu, Anita Etale, et al.
Clinical Nuclear Medicine|October 6, 2023
Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate Cancer Patients After Definitive Treatment With PSA Level ≤0.2 ng/mLYang Lu, Zenus J Wilson, Guofan Xu, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 13, 2023
Comparison of PSMA-based <sup>18</sup>F-DCFPyL PET/CT and pelvic multiparametric MRI for lesion detection in the pelvis in patients with prostate cancerTrinh T Nguyen, Priya R Bhosale, Guofan Xu, et al.
Magnetic Resonance Imaging|January 1, 2008
The phase shift index for marking functional asynchrony in Alzheimer's disease patients using fMRIYin Xu, Guofan Xu, Gaohong Wu, et al.
Neuroimage|June 2, 2009
Spatially augmented LPboosting for AD classification with evaluations on the ADNI datasetChris Hinrichs, Vikas Singh, Lopamudra Mukherjee, et al.
Current Oncology Reports|January 21, 2022
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic ApproachCamilo Jimenez, Guofan Xu, Jeena Varghese, et al.
Pageof 7